Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study

HJ Groen; ES Heijden; TJ Klinkenberg; B Biesma; Joachim Aerts; A Verhagen; C Kloosterziel; R Pieterman; B van den Borne; HJ Smit; O Hoekstra; F Schramel; V van der Noort; H van Tinteren; EF Smit; AMA Dingemans

doi:10.1038/s41416-019-0533-3

Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study

HJ Groen, ES Heijden, TJ Klinkenberg, B Biesma, Joachim Aerts, A Verhagen, C Kloosterziel, R Pieterman, B van den Borne, HJ Smit, O Hoekstra, F Schramel, V van der Noort, H van Tinteren, EF Smit, AMA Dingemans

Pulmonary Medicine

Research output: Contribution to journal › Article › Academic › peer-review

10 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	372-377
Number of pages	6
Journal	British Journal of Cancer
Volume	121
Issue number	5
DOIs	https://doi.org/10.1038/s41416-019-0533-3
Publication status	Published - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41416-019-0533-3

http://hdl.handle.net/1765/118400

Cite this

Groen, HJ., Heijden, ES., Klinkenberg, TJ., Biesma, B., Aerts, J., Verhagen, A., Kloosterziel, C., Pieterman, R., van den Borne, B., Smit, HJ., Hoekstra, O., Schramel, F., van der Noort, V., van Tinteren, H., Smit, EF., & Dingemans, AMA. (2019). Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study. British Journal of Cancer, 121(5), 372-377. https://doi.org/10.1038/s41416-019-0533-3

@article{566793dd9cc943d4a2a733d41b25b340,

title = "Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study",

author = "HJ Groen and ES Heijden and TJ Klinkenberg and B Biesma and Joachim Aerts and A Verhagen and C Kloosterziel and R Pieterman and {van den Borne}, B and HJ Smit and O Hoekstra and F Schramel and {van der Noort}, V and {van Tinteren}, H and EF Smit and AMA Dingemans",

year = "2019",

doi = "10.1038/s41416-019-0533-3",

language = "Undefined/Unknown",

volume = "121",

pages = "372--377",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "5",

}

Groen, HJ, Heijden, ES, Klinkenberg, TJ, Biesma, B, Aerts, J, Verhagen, A, Kloosterziel, C, Pieterman, R, van den Borne, B, Smit, HJ, Hoekstra, O, Schramel, F, van der Noort, V, van Tinteren, H, Smit, EF & Dingemans, AMA 2019, 'Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study', British Journal of Cancer, vol. 121, no. 5, pp. 372-377. https://doi.org/10.1038/s41416-019-0533-3

TY - JOUR

T1 - Randomised phase 3 study of adjuvant chemotherapy with or without nadroparin in patients with completely resected non-small-cell lung cancer: the NVALT-8 study

AU - Groen, HJ

AU - Heijden, ES

AU - Klinkenberg, TJ

AU - Biesma, B

AU - Aerts, Joachim

AU - Verhagen, A

AU - Kloosterziel, C

AU - Pieterman, R

AU - van den Borne, B

AU - Smit, HJ

AU - Hoekstra, O

AU - Schramel, F

AU - van der Noort, V

AU - van Tinteren, H

AU - Smit, EF

AU - Dingemans, AMA

PY - 2019

Y1 - 2019

U2 - 10.1038/s41416-019-0533-3

DO - 10.1038/s41416-019-0533-3

M3 - Article

VL - 121

SP - 372

EP - 377

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 5

ER -